These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3936450)

  • 21. Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children.
    Ghigo E; Bellone J; Aimaretti G; Bellone S; Loche S; Cappa M; Bartolotta E; Dammacco F; Camanni F
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3323-7. PubMed ID: 8784091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of the serotonin receptor subtype 5-HT1D on basal and stimulated growth hormone secretion.
    Mota A; Bento A; Peñalva A; Pombo M; Dieguez C
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1973-7. PubMed ID: 7775648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Augmentation by propranolol of growth hormone-releasing hormone-(1-44)-NH2-induced growth hormone release in normal short and normal children.
    Chihara K; Kodama H; Kaji H; Kita T; Kashio Y; Okimura Y; Abe H; Fujita T
    J Clin Endocrinol Metab; 1985 Aug; 61(2):229-33. PubMed ID: 2989315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulinhypoglycemia but not arginine infusion stimulates circulating plasma growth hormone-releasing hormone (GHRH) concentrations in children.
    Rosskamp R; Schmid G; Klumpp J; Tegeler A
    Horm Metab Res; 1987 Sep; 19(9):434-6. PubMed ID: 3121486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum growth hormone levels measured by radioimmunoassay and radioreceptor assay: a useful diagnostic tool in children with growth disorders?
    Ilondo MM; Vanderschueren-Lodeweyckx M; De Meyts P; Eggermont E
    J Clin Endocrinol Metab; 1990 May; 70(5):1445-51. PubMed ID: 2186059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatostatin pretreatment enhances growth hormone (GH) responsiveness to GH-releasing hormone: a potential new diagnostic approach to GH deficiency.
    Tzanela M; Guyda H; Van Vliet G; Tannenbaum GS
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2487-94. PubMed ID: 8675565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement of cholinergic tone by pyridostigmine promotes both basal and growth hormone (GH)-releasing hormone-induced GH secretion in children of short stature.
    Ghigo E; Mazza E; Imperiale E; Rizzi G; Benso L; Müller EE; Camanni F; Massara F
    J Clin Endocrinol Metab; 1987 Sep; 65(3):452-6. PubMed ID: 3114300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth hormone (GH) response to GH-releasing hormone in children with subnormal integrated concentrations of GH.
    Chalew SA; Armour KM; Levin PA; Thorner MO; Kowarski AA
    J Clin Endocrinol Metab; 1986 Jun; 62(6):1110-5. PubMed ID: 3084533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurotransmitter control of growth hormone secretion in children after cranial radiation therapy.
    Jorgensen EV; Schwartz ID; Hvizdala E; Barbosa J; Phuphanich S; Shulman DI; Root AW; Estrada J; Hu CS; Bercu BB
    J Pediatr Endocrinol; 1993; 6(2):131-42. PubMed ID: 8102303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results of 1-year growth hormone (GH)-releasing hormone-(1-44) treatment on growth, somatomedin-C, and 24-hour GH secretion in six children with partial GH deficiency.
    Rochiccioli PE; Tauber MT; Coude FX; Arnone M; Morre M; Uboldi F; Barbeau C
    J Clin Endocrinol Metab; 1987 Aug; 65(2):268-74. PubMed ID: 3110202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of overnight constant infusion of human growth hormone (GH)-releasing hormone-(1-44) on 24-hour GH secretion in children with partial GH deficiency.
    Rochiccioli PE; Tauber MT; Uboldi F; Coude FX; Morre M
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1100-5. PubMed ID: 3093519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth hormone responses to growth hormone-releasing hormone and clonidine before and after erythropoietin therapy in CAPD patients.
    Díez J; Iglesias P; Sastre J; Méndez J; Selgas R; Gómez-Pan A
    Nephron; 1996; 74(3):548-54. PubMed ID: 8938679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of oral clonidine, insulin-induced hypoglycemia and exercise on plasma GHRH levels in short-stature children.
    Gil-Ad I; Leibowitch N; Josefsberg Z; Wasserman M; Laron Z
    Acta Endocrinol (Copenh); 1990 Jan; 122(1):89-95. PubMed ID: 2106191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis of growth hormone (GH) deficiency in adults with hypothalamic-pituitary disorders: comparison of test results using pyridostigmine plus GH-releasing hormone (GHRH), clonidine plus GHRH, and insulin-induced hypoglycemia as GH secretagogues.
    Hoeck HC; Vestergaard P; Jakobsen PE; Falhof J; Laurberg P
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1467-72. PubMed ID: 10770183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absence of growth hormone (GH) secretion after the administration of either GH-releasing hormone (GHRH), GH-releasing peptide (GHRP-6), or GHRH plus GHRP-6 in children with neonatal pituitary stalk transection.
    Pombo M; Barreiro J; Peñalva A; Peino R; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3180-4. PubMed ID: 7593423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of growth hormone-releasing effect of growth hormone-releasing hormone, clonidine and pyridostigmine in normal children and adolescents. GH-releasing effect of GHRH, clonidine and pyridostigmine.
    Ghigo E; Arvat E; Nicolosi M; Mazza E; Camanni F
    Panminerva Med; 1990; 32(1):1-3. PubMed ID: 2263395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endogenous growth hormone (GH)-releasing hormone is required for GH responses to pharmacological stimuli.
    Jaffe CA; DeMott-Friberg R; Barkan AL
    J Clin Invest; 1996 Feb; 97(4):934-40. PubMed ID: 8613546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. L-dopa stimulates release of hypothalamic growth hormone-releasing hormone in humans.
    Chihara K; Kashio Y; Kita T; Okimura Y; Kaji H; Abe H; Fujita T
    J Clin Endocrinol Metab; 1986 Mar; 62(3):466-73. PubMed ID: 3080462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alpha 2-adrenergic agonism enhances the growth hormone (GH) response to GH-releasing hormone through an inhibition of hypothalamic somatostatin release in normal men.
    Devesa J; Arce V; Lois N; Tresguerres JA; Lima L
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1581-8. PubMed ID: 1977761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone, while alpha 2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men.
    Devesa J; Diaz MJ; Tresguerres JA; Arce V; Lima L
    J Clin Endocrinol Metab; 1991 Aug; 73(2):251-6. PubMed ID: 1677361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.